BrightSpring Health Services, Inc. Financials
This page shows BrightSpring Health Services, Inc. (BTSG) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 4 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2025 annual data. Scores normalized against common benchmarks. How we calculate these scores
BrightSpring Health Services, Inc. has an operating margin of 2.3%, meaning the company retains $2 of operating profit per $100 of revenue. This below-average margin results in a low score of 27/100, suggesting thin profitability after operating expenses. This is up from 1.1% the prior year.
BrightSpring Health Services, Inc.'s revenue surged 28.2% year-over-year to $12.9B, reflecting rapid business expansion. This strong growth earns a score of 80/100.
BrightSpring Health Services, Inc. carries a low D/E ratio of 1.31, meaning only $1.31 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 75/100, indicating a strong balance sheet with room for future borrowing.
BrightSpring Health Services, Inc.'s current ratio of 1.57 means current assets barely cover short-term liabilities. This tight liquidity results in a low score of 27/100, which could limit financial flexibility.
BrightSpring Health Services, Inc. has a free cash flow margin of 3.1%, earning a moderate score of 33/100. The company generates positive cash flow after capital investments, but with room for improvement.
BrightSpring Health Services, Inc.'s ROE of 10.2% shows moderate profitability relative to equity, earning a score of 34/100. This is up from -1.1% the prior year.
BrightSpring Health Services, Inc. scores 3.44, well above the 2.99 safe threshold. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
BrightSpring Health Services, Inc. passes 7 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.
For every $1 of reported earnings, BrightSpring Health Services, Inc. generates $2.57 in operating cash flow ($490.2M OCF vs $190.7M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
BrightSpring Health Services, Inc. earns $1.9 in operating income for every $1 of interest expense ($295.3M vs $157.3M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.
Key Financial Metrics
Earnings & Revenue
BrightSpring Health Services, Inc. generated $12.9B in revenue in fiscal year 2025. This represents an increase of 28.2% from the prior year.
BrightSpring Health Services, Inc.'s EBITDA was $459.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 47.1% from the prior year.
BrightSpring Health Services, Inc. reported $190.7M in net income in fiscal year 2025. This represents an increase of 1155.6% from the prior year.
BrightSpring Health Services, Inc. earned $0.87 per diluted share (EPS) in fiscal year 2025. This represents an increase of 1066.7% from the prior year.
Cash & Balance Sheet
BrightSpring Health Services, Inc. generated $394.7M in free cash flow in fiscal year 2025, representing cash available after capex. This represents an increase of 790.7% from the prior year.
BrightSpring Health Services, Inc. held $88.4M in cash against $2.5B in long-term debt as of fiscal year 2025.
BrightSpring Health Services, Inc. had 192M shares outstanding in fiscal year 2025. This represents an increase of 10.3% from the prior year.
Margins & Returns
BrightSpring Health Services, Inc.'s gross margin was 11.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 0.8 percentage points from the prior year.
BrightSpring Health Services, Inc.'s operating margin was 2.3% in fiscal year 2025, reflecting core business profitability. This is up 1.2 percentage points from the prior year.
BrightSpring Health Services, Inc.'s net profit margin was 1.5% in fiscal year 2025, showing the share of revenue converted to profit. This is up 1.7 percentage points from the prior year.
BrightSpring Health Services, Inc.'s ROE was 10.2% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 11.3 percentage points from the prior year.
Capital Allocation
BrightSpring Health Services, Inc. spent $43.2M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents an increase of 6542.0% from the prior year.
BrightSpring Health Services, Inc. invested $95.5M in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 18.0% from the prior year.
BTSG Income Statement
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.6B+6.5% | $3.3B+5.9% | $3.1B+9.4% | $2.9B+54.9% | $1.9B-36.1% | $2.9B+6.5% | $2.7B+6.0% | $2.6B |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | $2.5B+6.7% | $2.3B+6.1% | $2.2B |
| Gross Profit | $412.5M+5.2% | $392.0M+4.6% | $374.9M+10.8% | $338.4M-0.1% | $338.7M+4.8% | $323.1M+3.5% | $312.2M+6.7% | $292.5M |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $304.4M+0.1% | $304.2M-6.8% | $326.3M+13.4% | $287.6M+1.6% | $283.1M-3.7% | $294.0M+7.5% | $273.5M-11.1% | $307.8M |
| Operating Income | $108.1M+23.1% | $87.8M+80.9% | $48.6M-4.3% | $50.7M-8.6% | $55.5M+90.9% | $29.1M-24.7% | $38.7M+352.1% | -$15.3M |
| Interest Expense | $38.5M+0.8% | $38.2M-1.4% | $38.8M-7.1% | $41.8M-9.6% | $46.2M-0.9% | $46.6M+7.7% | $43.3M-20.5% | $54.5M |
| Income Tax | $20.0M+65.2% | $12.1M+879.0% | $1.2M+615.8% | -$240K-104.7% | $5.1M-37.7% | $8.2M+162.2% | -$13.1M+50.5% | -$26.5M |
| Net Income | $77.1M+38.0% | $55.8M+97.9% | $28.2M-4.5% | $29.5M+84.6% | $16.0M+294.4% | -$8.2M-141.3% | $19.9M+143.5% | -$45.8M |
| EPS (Diluted) | N/A | $0.26+100.0% | $0.13-7.1% | $0.14 | N/A | $-0.04-140.0% | $0.10+138.5% | $-0.26 |
BTSG Balance Sheet
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $6.4B+6.0% | $6.0B+1.8% | $5.9B+1.7% | $5.8B-1.3% | $5.9B+2.4% | $5.8B+3.2% | $5.6B-0.9% | $5.7B |
| Current Assets | $2.9B+4.1% | $2.8B+5.0% | $2.6B+4.7% | $2.5B+33.6% | $1.9B+10.7% | $1.7B+12.3% | $1.5B-3.2% | $1.6B |
| Cash & Equivalents | $88.4M-37.0% | $140.3M+100.3% | $70.1M+33.9% | $52.3M-14.1% | $61.0M+69.4% | $36.0M+43.7% | $25.0M-56.9% | $58.0M |
| Inventory | $815.2M+27.5% | $639.2M+2.2% | $625.5M+17.2% | $533.6M-16.2% | $636.6M+33.1% | $478.3M+27.8% | $374.3M+0.1% | $373.7M |
| Accounts Receivable | $989.7M-2.3% | $1.0B+4.1% | $972.7M-0.3% | $975.3M+8.0% | $902.8M-12.0% | $1.0B+4.2% | $984.8M-0.6% | $990.6M |
| Goodwill | $2.5B+7.4% | $2.4B0.0% | $2.4B0.0% | $2.4B+0.3% | $2.4B-11.6% | $2.7B+1.8% | $2.6B+0.7% | $2.6B |
| Total Liabilities | $4.5B+7.1% | $4.2B+0.7% | $4.2B+1.0% | $4.2B-2.8% | $4.3B+2.6% | $4.2B+4.2% | $4.0B-2.0% | $4.1B |
| Current Liabilities | $1.8B+19.3% | $1.5B+3.0% | $1.5B+3.3% | $1.5B+2.1% | $1.4B+13.0% | $1.3B+10.4% | $1.1B-8.0% | $1.2B |
| Long-Term Debt | $2.5B-0.4% | $2.5B-0.5% | $2.5B-0.5% | $2.5B-2.8% | $2.6B-1.8% | $2.6B+1.8% | $2.6B+1.9% | $2.5B |
| Total Equity | $1.9B+3.1% | $1.8B+4.3% | $1.7B+3.3% | $1.7B+2.4% | $1.6B+2.0% | $1.6B+1.0% | $1.6B+2.0% | $1.6B |
| Retained Earnings | -$74.6M+31.2% | -$108.6M+34.0% | -$164.4M+14.6% | -$192.6M+13.3% | -$222.2M+5.2% | -$234.4M-3.6% | -$226.2M+8.1% | -$246.1M |
BTSG Cash Flow Statement
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $231.6M+114.5% | $107.9M+119.9% | $49.1M-51.7% | $101.6M+12.1% | $90.6M+232.6% | $27.2M+279.0% | -$15.2M+80.7% | -$78.9M |
| Capital Expenditures | $37.7M+139.0% | $15.8M-35.5% | $24.4M+38.5% | $17.6M+15.2% | $15.3M-23.6% | $20.0M-15.6% | $23.7M+8.8% | $21.8M |
| Free Cash Flow | $193.9M+110.4% | $92.2M+273.9% | $24.7M-70.6% | $84.0M+11.5% | $75.3M+945.4% | $7.2M+118.5% | -$39.0M+61.3% | -$100.7M |
| Investing Cash Flow | -$233.9M-884.3% | -$23.8M-2.2% | -$23.2M+3.9% | -$24.2M-53.3% | -$15.8M+56.0% | -$35.8M+37.9% | -$57.7M-86.5% | -$30.9M |
| Financing Cash Flow | -$50.5M-285.3% | -$13.1M-59.0% | -$8.2M+90.4% | -$86.0M-73.6% | -$49.6M-353.8% | $19.5M-51.1% | $39.9M-74.2% | $154.8M |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | N/A | N/A | N/A | N/A | $0 | $0-100.0% | $325K0.0% | $325K |
BTSG Financial Ratios
| Metric | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 11.6%-0.1pp | 11.8%-0.2pp | 11.9%+0.2pp | 11.8%-6.5pp | 18.2%+7.1pp | 11.1%-0.3pp | 11.4%+0.1pp | 11.3% |
| Operating Margin | 3.0%+0.4pp | 2.6%+1.1pp | 1.5%-0.2pp | 1.8%-1.2pp | 3.0%+2.0pp | 1.0%-0.4pp | 1.4%+2.0pp | -0.6% |
| Net Margin | 2.2%+0.5pp | 1.7%+0.8pp | 0.9%-0.1pp | 1.0%+0.2pp | 0.9%+1.1pp | -0.3%-1.0pp | 0.7%+2.5pp | -1.8% |
| Return on Equity | 4.1%+1.0pp | 3.1%+1.5pp | 1.6%-0.1pp | 1.8%+0.8pp | 1.0%+1.5pp | -0.5%-1.8pp | 1.3%+4.2pp | -2.9% |
| Return on Assets | 1.2%+0.3pp | 0.9%+0.4pp | 0.5%-0.0pp | 0.5%+0.2pp | 0.3%+0.4pp | -0.1%-0.5pp | 0.4%+1.2pp | -0.8% |
| Current Ratio | 1.57-0.2 | 1.79+0.0 | 1.76+0.0 | 1.73+0.4 | 1.33-0.0 | 1.35+0.0 | 1.33+0.1 | 1.26 |
| Debt-to-Equity | 1.31-0.0 | 1.36-0.1 | 1.42-0.1 | 1.48-0.1 | 1.55-0.1 | 1.62+0.0 | 1.600.0 | 1.60 |
| FCF Margin | 5.5%+2.7pp | 2.8%+2.0pp | 0.8%-2.1pp | 2.9%-1.1pp | 4.0%+3.8pp | 0.3%+1.7pp | -1.4%+2.5pp | -3.9% |
Similar Companies
Frequently Asked Questions
What is BrightSpring Health Services, Inc.'s annual revenue?
BrightSpring Health Services, Inc. (BTSG) reported $12.9B in total revenue for fiscal year 2025. This represents a 28.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is BrightSpring Health Services, Inc.'s revenue growing?
BrightSpring Health Services, Inc. (BTSG) revenue grew by 28.2% year-over-year, from $10.1B to $12.9B in fiscal year 2025.
Is BrightSpring Health Services, Inc. profitable?
Yes, BrightSpring Health Services, Inc. (BTSG) reported a net income of $190.7M in fiscal year 2025, with a net profit margin of 1.5%.
What is BrightSpring Health Services, Inc.'s EBITDA?
BrightSpring Health Services, Inc. (BTSG) had EBITDA of $459.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does BrightSpring Health Services, Inc. have?
As of fiscal year 2025, BrightSpring Health Services, Inc. (BTSG) had $88.4M in cash and equivalents against $2.5B in long-term debt.
What is BrightSpring Health Services, Inc.'s gross margin?
BrightSpring Health Services, Inc. (BTSG) had a gross margin of 11.8% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is BrightSpring Health Services, Inc.'s operating margin?
BrightSpring Health Services, Inc. (BTSG) had an operating margin of 2.3% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is BrightSpring Health Services, Inc.'s net profit margin?
BrightSpring Health Services, Inc. (BTSG) had a net profit margin of 1.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is BrightSpring Health Services, Inc.'s return on equity (ROE)?
BrightSpring Health Services, Inc. (BTSG) has a return on equity of 10.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is BrightSpring Health Services, Inc.'s free cash flow?
BrightSpring Health Services, Inc. (BTSG) generated $394.7M in free cash flow during fiscal year 2025. This represents a 790.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is BrightSpring Health Services, Inc.'s operating cash flow?
BrightSpring Health Services, Inc. (BTSG) generated $490.2M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are BrightSpring Health Services, Inc.'s total assets?
BrightSpring Health Services, Inc. (BTSG) had $6.4B in total assets as of fiscal year 2025, including both current and long-term assets.
What are BrightSpring Health Services, Inc.'s capital expenditures?
BrightSpring Health Services, Inc. (BTSG) invested $95.5M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
What is BrightSpring Health Services, Inc.'s current ratio?
BrightSpring Health Services, Inc. (BTSG) had a current ratio of 1.57 as of fiscal year 2025, which is generally considered healthy.
What is BrightSpring Health Services, Inc.'s debt-to-equity ratio?
BrightSpring Health Services, Inc. (BTSG) had a debt-to-equity ratio of 1.31 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is BrightSpring Health Services, Inc.'s return on assets (ROA)?
BrightSpring Health Services, Inc. (BTSG) had a return on assets of 3.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is BrightSpring Health Services, Inc.'s Altman Z-Score?
BrightSpring Health Services, Inc. (BTSG) has an Altman Z-Score of 3.44, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios—working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets—to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is BrightSpring Health Services, Inc.'s Piotroski F-Score?
BrightSpring Health Services, Inc. (BTSG) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are BrightSpring Health Services, Inc.'s earnings high quality?
BrightSpring Health Services, Inc. (BTSG) has an earnings quality ratio of 2.57x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can BrightSpring Health Services, Inc. cover its interest payments?
BrightSpring Health Services, Inc. (BTSG) has an interest coverage ratio of 1.9x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is BrightSpring Health Services, Inc.?
BrightSpring Health Services, Inc. (BTSG) scores 46 out of 100 on our Financial Profile, indicating moderate overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.